v3.22.4

Commitments and Contingencies | 12 Months Ended
--- | ---
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract] |
Commitments and Contingencies | Commitments and Contingencies Leases Operating leases The Company leases approximately 35,823 square feet of office, laboratory, and manufacturing space in two buildings at our headquarters in San Diego, California, with the lease for all rented space expiring December 31, 2025. In December 2021, the Company executed a new lease for approximately 11,978 additional square feet square feet of office and laboratory space in San Diego, California that expires in January 2026. In January 2022, the Company executed a new lease for an additional 5,278 square feet of office and laboratory space in San Diego, California that expires in January 2026. In December 2022, the Company executed a new lease, subject to the consent of a third party that was obtained in February 2023, for an additional 18,005 square feet of office and laboratory space in San Diego, California that commences in April 2023 and expires in March 2024. Rent payments for the additional space are $49,000 each month through the end of the lease term. In August 2020, through the acquisition of Lineagen, the Company obtained a lease for approximately 9,710 square feet of office space in a Salt Lake City, Utah under a non-cancelable operating lease that expires in December 2026. In November 2022, through the acquisition of Purigen, the Company obtained a lease for approximately 16,165 square feet of office and laboratory space in Pleasanton, California, under a non-cancelable operating lease agreement that expires in July 2027. Finance lease In October 2021, through the acquisition of BioDiscovery, the Company obtained a finance lease of 4,786 square feet of office space in El Segundo, California that expires in February 2041. The portion of the future payments designated as principal repayment and related interest was classified as a finance lease obligation on our consolidated balance sheets. Refer to Note 15. Related Party Transactions for additional information. Supplemental information For all leases, the Company has the ability to enter into renewal negotiations, prior to the lease end date, with no specific terms. At this time, it is not reasonably certain that we will extend the term of the lease and therefore the renewal period has been excluded from the aforementioned ROU asset and lease liability measurements. The leases are subject to variable charges for common area maintenance and other costs that are determined based on actual costs and includes certain lease incentives such as tenant improvement allowances. The base rent for the leases is subject to an annual increase each year. Rent expense is being recognized on a straight-line basis over the term of the lease. The Company’s estimated incremental borrowing rate summarized in the table below was used in its present value calculations as the operating and finance leases do not have a stated rate and the implicit rate was not readily determinable. In determining the incremental borrowing rate, the Company considered the interest rate of the Term Loans as well as publicly available data for discount rates used by peer companies. Supplemental information pertaining to the Company’s leases in which the Company is the lessee is as follows:
|  |  |  |  | Year Ended December 31,
|  |  |  |  | 2022 |  | 2021
Cash payments included in the measurement of lease liabilities: |  |  |  |  |  |  |
Operating cash flows from operating leases |  |  |  |  | $ | 1,622,000 |  | $ | 447,000
Operating cash flows from finance leases |  |  |  |  | $ | 278,000 |  | $ | 47,000
Financing cash flows from finance leases |  |  |  |  | $ | 36,000 |  | $ | 5,000
Weighted-average remaining lease term: |  |  |  |  |  |  |
Operating leases |  |  |  |  | 3.41 years |  | 4.10 years
Finance leases |  |  |  |  | 18.17 years |  | 19.20 years
Weighted-average discount rate: |  |  |  |  |  |  |
Operating leases |  |  |  |  | 8.3 | % |  | 7.1 | %
Finance leases |  |  |  |  | 7.1 | % |  | 7.1 | %
Noncash lease liabilities resulting from obtaining right-of-use assets |  |  |  |  |  |  |
Operating leases |  |  |  |  | $ | 517,000 |  | $ | 4,751,000
The following table provides the components of the Company’s lease cost:
| Year Ended December 31,
| 2022 |  | 2021
Operating leases |  |  |
Operating lease costs | $ | 2,084,000 |  |  | $ | 1,118,000 |
Variable lease costs | 940,000 |  |  | 386,000 |
Total rent expense | 3,024,000 |  |  | 1,504,000 |
Finance lease |  |  |
Amortization of right of use assets | 219,000 |  |  | 19,000 |
Interest on lease liabilities | 278,000 |  |  | 47,000 |
Variable lease costs | 32,000 |  |  | — |
Total finance lease costs | 529,000 |  |  | 66,000 |
Gross sublease income | (106,000) |  |  | (18,000) |
Total lease costs | $ | 3,447,000 |  |  | $ | 1,552,000 |
The future minimum payments under non-cancellable operating and finance leases as of December 31, 2022, are as follows:
| Operating Leases |  | Finance Lease
2023 | $ | 2,586,000 |  |  | $ | 322,000 |
2024 | 2,684,000 |  |  | 330,000 |
2025 | 2,788,000 |  |  | 338,000 |
2026 | 729,000 |  |  | 347,000 |
2027 | 255,000 |  |  | 356,000 |
Thereafter | — |  |  | 5,594,000 |
Total future lease payments | 9,042,000 |  |  | 7,287,000 |
Less: imputed interest | (1,278,000) |  |  | (3,383,000) |
Total lease liabilities | 7,764,000 |  |  | 3,904,000 |
Less: lease liability, current portion | 2,260,000 |  |  | 285,000 |
Lease liability, net of current portion | $ | 5,504,000 |  |  | $ | 3,619,000 |
Purchase Commitments The Company has a contractual commitment with a supplier to purchase $0.3 million of products every month for an initial term of two years beginning in May 2021 until May 2023. $3.2 million and $1.9 million of materials were purchased under this minimum purchase commitment during the years ended December 31, 2022 and 2021, respectively. The contract can be terminated with 90 days written notice by either party. Litigation From time to time, the Company may be subject to potential liabilities under various claims and legal actions that are pending or may be asserted. These matters arise in the ordinary course and conduct of the business. The Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it currently does not have any material loss exposure as it is not a defendant in any claims or legal actions. Contingent Consideration Refer to Note 4. Investments and Fair Value Measurements for discussion regarding contingent consideration.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -URI https://asc.fasb.org/topic&trid=2144648 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 440 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -URI https://asc.fasb.org/topic&trid=2127136 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308 + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration